Danielle Blanch-Hartigan1, Laura P Forsythe2, Catherine M Alfano2, Tenbroeck Smith2, Larissa Nekhlyudov2, Patricia A Ganz2, Julia H Rowland2. 1. Danielle Blanch-Hartigan, Catherine M. Alfano, and Julia H. Rowland, National Cancer Institute, Bethesda, MD; Laura P. Forsythe, Patient-Centered Outcomes Research Institute, Washington, DC; Tenbroeck Smith, American Cancer Society, Atlanta, GA; Larissa Nekhlyudov, Harvard Medical School and Harvard Vanguard Medical Associates, Boston, MA; and Patricia A. Ganz, University of California Los Angeles Schools of Medicine and Public Health, Los Angeles, CA. danielle.hartigan@nih.gov. 2. Danielle Blanch-Hartigan, Catherine M. Alfano, and Julia H. Rowland, National Cancer Institute, Bethesda, MD; Laura P. Forsythe, Patient-Centered Outcomes Research Institute, Washington, DC; Tenbroeck Smith, American Cancer Society, Atlanta, GA; Larissa Nekhlyudov, Harvard Medical School and Harvard Vanguard Medical Associates, Boston, MA; and Patricia A. Ganz, University of California Los Angeles Schools of Medicine and Public Health, Los Angeles, CA.
Abstract
PURPOSE: Survivorship care planning should involve discussions between providers and cancer survivors to address survivors' needs and optimize adherence. We examined the frequency and factors associated with oncologists' and primary care physicians' (PCPs) reports of provision of written survivorship care plans (SCPs) and discussion of survivorship care recommendations with survivors. METHODS: A nationally representative sample of 1,130 oncologists and 1,020 PCPs was surveyed about survivorship care practices with survivors. Logistic regression models predicted multilevel factors associated with providing SCPs or discussing recommendations with survivors. RESULTS: Although a majority of oncologists (64%) reported always/almost always discussing survivorship care recommendations with survivors, fewer also discussed who survivors should see for cancer-related and other follow-up care (32%); fewer still also provided a written SCP to the survivor (< 5%). Survivorship care recommendations and provider responsibility were not regularly discussed by PCPs and survivors (12%). Oncologists who reported detailed training about late and long-term effects of cancer were more likely to provide written SCPs (odds ratio [OR], 1.73; 95% CI, 1.22 to 2.44) and discuss survivorship care planning with survivors (OR, 2.02; 95% CI, 1.51 to 2.70). PCPs who received SCPs from oncologists were 9× more likely (95% CI, 5.74 to 14.82) to report survivorship discussions with survivors. CONCLUSION: A minority of both PCPs and oncologists reported consistently discussing and providing SCPs to cancer survivors. Training and knowledge specific to survivorship care and coordinated care between PCPs and oncologists were associated with increased survivorship discussions with survivors. These nationally representative data provide a useful benchmark to assess implementation of new efforts to improve the follow-up care of survivors.
PURPOSE: Survivorship care planning should involve discussions between providers and cancer survivors to address survivors' needs and optimize adherence. We examined the frequency and factors associated with oncologists' and primary care physicians' (PCPs) reports of provision of written survivorship care plans (SCPs) and discussion of survivorship care recommendations with survivors. METHODS: A nationally representative sample of 1,130 oncologists and 1,020 PCPs was surveyed about survivorship care practices with survivors. Logistic regression models predicted multilevel factors associated with providing SCPs or discussing recommendations with survivors. RESULTS: Although a majority of oncologists (64%) reported always/almost always discussing survivorship care recommendations with survivors, fewer also discussed who survivors should see for cancer-related and other follow-up care (32%); fewer still also provided a written SCP to the survivor (< 5%). Survivorship care recommendations and provider responsibility were not regularly discussed by PCPs and survivors (12%). Oncologists who reported detailed training about late and long-term effects of cancer were more likely to provide written SCPs (odds ratio [OR], 1.73; 95% CI, 1.22 to 2.44) and discuss survivorship care planning with survivors (OR, 2.02; 95% CI, 1.51 to 2.70). PCPs who received SCPs from oncologists were 9× more likely (95% CI, 5.74 to 14.82) to report survivorship discussions with survivors. CONCLUSION: A minority of both PCPs and oncologists reported consistently discussing and providing SCPs to cancer survivors. Training and knowledge specific to survivorship care and coordinated care between PCPs and oncologists were associated with increased survivorship discussions with survivors. These nationally representative data provide a useful benchmark to assess implementation of new efforts to improve the follow-up care of survivors.
Authors: Mary S McCabe; Smita Bhatia; Kevin C Oeffinger; Gregory H Reaman; Courtney Tyne; Dana S Wollins; Melissa M Hudson Journal: J Clin Oncol Date: 2013-01-07 Impact factor: 44.544
Authors: Terry S Field; Chyke Doubeni; Matthew P Fox; Diana S M Buist; Feifei Wei; Ann M Geiger; Virginia P Quinn; Timothy L Lash; Marianne N Prout; Marianne Ulcickas Yood; Floyd J Frost; Rebecca A Silliman Journal: J Gen Intern Med Date: 2007-12-01 Impact factor: 5.128
Authors: Smita C Banerjee; Matthew J Matasar; Carma L Bylund; Steven Horwitz; Kara McLarney; Tomer Levin; Paul B Jacobsen; Patricia Parker; Alan Astrow; David W Kissane Journal: Transl Behav Med Date: 2015-06-02 Impact factor: 3.046
Authors: Denalee O'Malley; Shawna V Hudson; Larissa Nekhlyudov; Jenna Howard; Ellen Rubinstein; Heather S Lee; Linda S Overholser; Amy Shaw; Sarah Givens; Jay S Burton; Eva Grunfeld; Carly Parry; Benjamin F Crabtree Journal: J Cancer Surviv Date: 2016-06-08 Impact factor: 4.442
Authors: Carol A Rosenberg; Carol Flanagan; Bruce Brockstein; Jennifer C Obel; Leon H Dragon; Douglas E Merkel; Elaine L Wade; Teresa M Law; Janardan D Khandekar; Thomas A Hensing Journal: J Cancer Surviv Date: 2015-07-16 Impact factor: 4.442
Authors: Simon J Craddock Lee; Mark A Clark; John V Cox; Burton M Needles; Carole Seigel; Bijal A Balasubramanian Journal: J Oncol Pract Date: 2016-10-31 Impact factor: 3.840
Authors: Amye J Tevaarwerk; Jennifer R Klemp; Gijsberta J van Londen; Bradford W Hesse; Mary E Sesto Journal: Cancer Date: 2018-09-12 Impact factor: 6.860